FASEB journal : official publication of the Federation of American Societies for Experimental BiologyCognitive DysfunctionHumansAlzheimer DiseaseBiomarkersMale
Multiplex Cerebrospinal Fluid Proteomics Identifies Biomarkers Predicting Neuropsychiatric Symptom Progression in Mild Cognitive Impairment and Alzheimer's Disease.
Xue Han, Shouqiang Zhu, Heng Zhang, Tianjiao Xia, Xiaoping Gu
Published: 202610.1096/fj.202504014R
Abstract
Neuropsychiatric symptoms (NPS), commonly concomitant with Alzheimer's disease (AD), substantially impair the quality of life and accelerate disease progression, yet reliable biomarkers for early identification of individuals at high NPS risk remain…
Preview only. Read the full abstract at the source